• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用基于人群的关联数据比较前列腺癌患者治疗后的泌尿系统和结直肠手术情况。

Comparing post-treatment urinary and colorectal procedures in prostate cancer patients using population-based linked data.

作者信息

Tiruye Tenaw, Jay Alex, Higgs Braden, O'Callaghan Michael, FitzGerald Liesel M, Moretti Kim, Roder David, Beckmann Kerri

机构信息

Allied Health and Human Performance, University of South Australia, Adelaide, Australia.

School of Public Health, Debre Markos University, Debre Markos, Ethiopia.

出版信息

Int Urol Nephrol. 2025 Apr;57(4):1189-1198. doi: 10.1007/s11255-024-04304-1. Epub 2024 Dec 10.

DOI:10.1007/s11255-024-04304-1
PMID:39658770
Abstract

PURPOSE

To investigate urinary and colorectal procedures among men who underwent radical prostatectomy (RP) and external beam radiotherapy (EBRT).

METHODS

We studied 16,271 (RP = 8516 and EBRT = 7755) South Australian men diagnosed with prostate cancer between 2001 and 2021. Colorectal and urinary procedures were extracted from hospital admission procedure codes and Medical Benefits Schedule item codes. Rates were estimated at 30-days, 90-days, 6-months, 1-year, 2-years and 5-years post-treatment. We estimated the average treatment effect of RP (compared with EBRT) by applying propensity-matched analyses, accounting for sociodemographic and clinical characteristics. Subgroup analyses were undertaken for different treatment periods (2001-2010 vs. 2011-2021).

RESULTS

At 1-year post-treatment, the crude rates of colorectal procedures were 43 and 70/1000 person-years among RP and EBRT patients, respectively, while crude rates for urinary procedures were 258 and 74/1000 person-years, respectively. Propensity matched analyses indicated that patients undergoing RP underwent more post-treatment urinary procedures, being 21.2% higher at 6-months and 16.3% higher at 5-years than men who received EBRT. Colorectal procedures were slightly more frequent among RP than EBRT patients during the first 90-days but less frequent from 1-year onwards (5.9% lower at 5-years among RP group). Between 2011 and 2021, there were considerably fewer urinary procedures for men who underwent RP than those treated between 2001 and 2010.

CONCLUSION

There is a statistically significant difference in the frequency of post-treatment procedures between patients who underwent RP and those who had EBRT, which likely indicates a difference in adverse treatment effects. These findings may lead to more informed treatment decision-making.

摘要

目的

调查接受根治性前列腺切除术(RP)和体外放射治疗(EBRT)的男性患者的泌尿系统和结直肠手术情况。

方法

我们研究了2001年至2021年间在南澳大利亚被诊断为前列腺癌的16271名男性(RP组 = 8516人,EBRT组 = 7755人)。结直肠和泌尿系统手术信息从医院入院手术编码和医疗福利计划项目编码中提取。在治疗后30天、90天、6个月、1年、2年和5年时估计发生率。我们通过应用倾向匹配分析估计了RP(与EBRT相比)的平均治疗效果,并考虑了社会人口统计学和临床特征。对不同治疗时期(2001 - 2010年与2011 - 2021年)进行了亚组分析。

结果

治疗后1年,RP组和EBRT组患者的结直肠手术粗发生率分别为每1000人年43例和70例,而泌尿系统手术粗发生率分别为每1000人年258例和74例。倾向匹配分析表明,接受RP治疗的患者术后泌尿系统手术更多,在6个月时比接受EBRT的男性高21.2%,在5年时高16.3%。在最初的90天内,RP组的结直肠手术比EBRT组稍多,但从1年起则较少(RP组在5年时低5.9%)。2011年至2021年间,接受RP治疗的男性的泌尿系统手术比2001年至2010年间接受治疗的男性少得多。

结论

接受RP治疗的患者与接受EBRT治疗的患者术后手术频率存在统计学上的显著差异,这可能表明不良治疗效果存在差异。这些发现可能有助于做出更明智的治疗决策。

相似文献

1
Comparing post-treatment urinary and colorectal procedures in prostate cancer patients using population-based linked data.利用基于人群的关联数据比较前列腺癌患者治疗后的泌尿系统和结直肠手术情况。
Int Urol Nephrol. 2025 Apr;57(4):1189-1198. doi: 10.1007/s11255-024-04304-1. Epub 2024 Dec 10.
2
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.与根治性前列腺切除术相比,外照射放疗会增加前列腺癌患者患膀胱癌的风险:一项基于人群的分析。
Eur Urol. 2019 Feb;75(2):319-328. doi: 10.1016/j.eururo.2018.09.034. Epub 2018 Oct 4.
3
A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.一项针对接受根治性前列腺切除术、体外放射治疗或组织间近距离放射治疗的临床局限性前列腺癌男性患者的前瞻性生活质量研究。
Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):614-23. doi: 10.1016/s0360-3016(01)01707-2.
4
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.根治性前列腺切除术、外照射放疗、外照射放疗联合近距离放疗增敏与 Gleason 评分 9 - 10 前列腺癌患者的疾病进展及死亡率
JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.
5
Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.接受根治性前列腺切除术或外照射放疗治疗局限性前列腺癌的男性患者的肿瘤学结果、功能结局及健康相关生活质量:一项基于风险分层的长期患者结局研究
Asian J Androl. 2009 May;11(3):283-90. doi: 10.1038/aja.2009.10. Epub 2009 Apr 6.
6
Survival after radiotherapy vs. radical prostatectomy for unfavorable intermediate-risk prostate cancer.中危前列腺癌放疗与根治性前列腺切除术的生存比较。
Urol Oncol. 2019 Nov;37(11):813.e11-813.e19. doi: 10.1016/j.urolonc.2019.04.022. Epub 2019 May 18.
7
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.前列腺癌严重程度对局部治疗后功能结局的影响:手术和放疗研究结果的比较效果分析。
Eur Urol. 2018 Jul;74(1):26-33. doi: 10.1016/j.eururo.2018.02.012. Epub 2018 Feb 28.
8
Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.前列腺癌手术、放疗或两者联合治疗后的尿不良事件长期倾向性风险。
Eur Urol. 2015 Feb;67(2):273-80. doi: 10.1016/j.eururo.2014.08.061. Epub 2014 Sep 10.
9
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis.在前列腺活检中格里森评分 9-10 的前列腺癌患者中,根治性前列腺切除术与外照射放疗的生存结局比较:一项基于人群的分析。
Urol Oncol. 2020 Mar;38(3):79.e9-79.e14. doi: 10.1016/j.urolonc.2019.09.015. Epub 2019 Oct 23.
10
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.局限性前列腺癌的放射治疗、手术或观察与3年后患者报告结局之间的关联
JAMA. 2017 Mar 21;317(11):1126-1140. doi: 10.1001/jama.2017.1704.

引用本文的文献

1
Socioeconomic and Geographic Disparities in Anorectal and Urinary Procedures Following Radiotherapy for Prostate Cancer.前列腺癌放疗后肛肠和泌尿系统手术的社会经济及地理差异
Cancer Med. 2025 Aug;14(15):e71135. doi: 10.1002/cam4.71135.
2
Post-prostatectomy rehospitalisation rates and risk factors in South Australian men with prostate cancer: evidence from linked data.南澳大利亚州前列腺癌男性患者前列腺切除术后再入院率及危险因素:来自关联数据的证据
Int Urol Nephrol. 2025 Jul 25. doi: 10.1007/s11255-025-04691-z.

本文引用的文献

1
Social determinants of health and surgical outcomes of minimally invasive radical prostatectomy: a national population-based study.健康的社会决定因素与微创根治性前列腺切除术的手术结果:一项基于全国人口的研究。
Prostate Cancer Prostatic Dis. 2024 Oct 24. doi: 10.1038/s41391-024-00913-0.
2
Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort study.合并症对前列腺癌特异性死亡率的影响:一项基于人群的队列研究。
Prostate. 2024 Sep;84(12):1138-1145. doi: 10.1002/pros.24750. Epub 2024 May 26.
3
Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection.
基于药物的共病测量与前列腺癌治疗选择
Clin Genitourin Cancer. 2024 Apr;22(2):599-609.e2. doi: 10.1016/j.clgc.2024.01.018. Epub 2024 Feb 1.
4
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study.前列腺癌根治性前列腺切除术或放疗 1 年后患者报告的副作用:基于登记的全国性研究。
Eur Urol Oncol. 2024 Jun;7(3):605-613. doi: 10.1016/j.euo.2023.12.007. Epub 2024 Jan 16.
5
Clinical and functional outcomes for risk-appropriate treatments for prostate cancer.前列腺癌风险适配治疗的临床和功能结果。
BJUI Compass. 2023 Sep 12;5(1):109-120. doi: 10.1002/bco2.288. eCollection 2024 Jan.
6
Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer.基于处方的合并症指数在预测澳大利亚前列腺癌男性患者死亡率中的效用。
Cancer Epidemiol. 2024 Feb;88:102516. doi: 10.1016/j.canep.2023.102516. Epub 2023 Dec 22.
7
Risk of secondary malignancy following radiation therapy for prostate cancer.前列腺癌放疗后的继发恶性肿瘤风险。
Sci Rep. 2023 Nov 16;13(1):20083. doi: 10.1038/s41598-023-45856-z.
8
Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study.保留Retzius 间隙与标准机器人辅助根治性前列腺切除术治疗局限性前列腺癌的比较研究。
Prostate Cancer Prostatic Dis. 2023 Sep;26(3):568-574. doi: 10.1038/s41391-022-00625-3. Epub 2022 Nov 29.
9
Patient-reported functional outcome measures and treatment choice for prostate cancer.患者报告的前列腺癌功能结局测量指标和治疗选择。
BMC Urol. 2022 Nov 5;22(1):169. doi: 10.1186/s12894-022-01117-1.
10
Ten-year treatment complication outcomes of radical prostatectomy vs external beam radiation vs brachytherapy for 1503 patients with intermediate risk prostate cancer.1503 例中危前列腺癌患者根治性前列腺切除术、外照射放疗与近距离放疗 10 年治疗并发症结局比较。
Brachytherapy. 2021 Nov-Dec;20(6):1083-1089. doi: 10.1016/j.brachy.2021.04.004. Epub 2021 Jun 3.